Cover Image

A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease

Background. Promising results regarding potential anti-inflammatory and antiatherosclerotic effects of gliptins have been reported. Our aim was to investigate whether saxagliptin treatment modifies expression of inflammatory markers, primarily in peripheral blood mononuclear cells (PBMCs) and in cir...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ida Unhammer Njerve (Author), Sissel Åkra (Author), Thomas W. Weiss (Author), Svein Solheim (Author), Reidun Øvstebø (Author), Hans Christian D. Aass (Author), Rune Byrkjeland (Author), Harald Arnesen (Author), Ingebjørg Seljeflot (Author)
Format:	Book
Published:	Hindawi Limited, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects on Serum Fractalkine by Diet and Omega-3 Fatty Acid Intervention: Relation to Clinical Outcome
by: Kristian Laake, et al.
Published: (2015)

The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
by: Ragnhild Helseth, et al.
Published: (2016)

The Time Profile of Pentraxin 3 in Patients with Acute ST-Elevation Myocardial Infarction and Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
by: Ragnhild Helseth, et al.
Published: (2014)

The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
by: Jostein Nordeng, et al.
Published: (2021)

Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease
by: Karsten E. Kluge, et al.
Published: (2020)

The Influence of Autologous Bone Marrow Stem Cell Transplantation on Matrix Metalloproteinases in Patients Treated for Acute ST-Elevation Myocardial Infarction
by: Eline Bredal Furenes, et al.
Published: (2014)

Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly
by: Dennis Winston T. Nilsen, et al.
Published: (2023)

Role of saxagliptin as monotherapy or adjunct therapy in the treatment of type 2 diabetes
by: Morali D Sharma
Published: (2010)

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients
by: Konya H, et al.
Published: (2014)

Spectrophotometric and spectrofluorimetric methods for the determination of saxagliptin and vildagliptin in bulk and pharmaceutical preparations
by: Marwa S. Moneeb
Published: (2013)

Process Study on the Enzyme-Catalyzed Preparation of Key Chiral Intermediates for Saxagliptin
by: Shan-Shan Li, et al.
Published: (2022)

Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
by: Ragnhild Helseth, et al.
Published: (2019)

Pharmacokinetic interaction of saxagliptin with andrographolide and their hypoglycemic effect in type 2 diabetes rats
by: Suyan Wu, et al.
Published: (2023)

Chromatographic methods for the simultaneous determination of binary mixture of Saxagliptin HCl and Metformin HCl
by: Hanan A. Merey, et al.
Published: (2017)

Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin
by: Blaž Robnik, et al.
Published: (2019)

Evaluation of the Drug-Induced Liver Injury Potential of Saxagliptin through Reactive Metabolite Identification in Rats
by: Ki-Young Kim, et al.
Published: (2024)

Stability indicating RP-LC-PDA method for the quantitative analysis of saxagliptin in pharmaceutical dosage form
by: Laís Engroff Scheeren, et al.
Published: (2015)

Psychiatric Disorders and ADD
by: J Gordon Millichap
Published: (1988)

Language Disorders and ADD
by: J Gordon Millichap
Published: (1988)

Multivariate optimization of liquid chromatographic conditions for determination of dapagliflozin and saxagliptin, application to an in vitro dissolution and stability studies
by: Sunitha Gurrala, et al.
Published: (2021)

Increased SIRT1 Concentration Following Four Years of Selenium and Q<sub>10</sub> Intervention Associated with Reduced Cardiovascular Mortality at 10-Year Follow-Up-Sub-Study of a Previous Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial
by: Trine Baur Opstad, et al.
Published: (2023)

Saxagliptin Attenuates Albuminuria by Inhibiting Podocyte Epithelial- to-Mesenchymal Transition via SDF-1α in Diabetic Nephropathy
by: Yun-peng Chang, et al.
Published: (2017)

Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats
by: Junichi Ikeda, et al.
Published: (2016)

Methylphenidate, Add, and Classroom Performance
by: J Gordon Millichap
Published: (1993)

Aspartame, Behavior, and Cognition in ADD
by: J Gordon Millichap
Published: (1994)

Auditory Evoked Potentials in ADD
by: J Gordon Millichap
Published: (1995)

Application of quality by design approach in RP-HPLC method development for simultaneous estimation of saxagliptin and dapagliflozin in tablet dosage form
by: Aruna Gundala, et al.
Published: (2019)

EFFECT OF DOUBLE HYPOGLYCEMIC THERAPY WITH METFORMIN AND SAXAGLIPTIN, ON ACHIEVEMENT OF GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND ADJUVANT OBESITY
by: Liliia Nikulina
Published: (2018)

Lixisenatide as add-on therapy to basal insulin
by: Brown DX, et al.
Published: (2013)

Yoga as an add-on therapy in the management of migraine
by: Sachin Kumar Sharma, et al.
Published: (2020)

Fenfluramine Add-On Therapy of Dravet Syndrome
by: J Gordon Millichap
Published: (2012)

Gabapentin Add-On Therapy for Partial Seizures
by: J Gordon Millichap
Published: (2001)

Vascular Function in Norwegian Female Elite Runners: A Cross-Sectional, Controlled Study
by: Karoline Holsen Kyte, et al.
Published: (2022)

15-åringers opplevelser av overvekt hos jevnaldrende, en fenomenologisk-hermeneutisk studie
by: Reidun Rognsaa, et al.
Published: (2011)

The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo
by: Masako Uchii, et al.
Published: (2017)

Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II
by: Enrico Torre, et al.
Published: (2020)

Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole
by: Patel C, et al.
Published: (2011)

Global Critical Care: Add Essentials to the Roadmap
by: Carl Otto Schell, et al.
Published: (2019)

Improved anorgasmia following add-on lamotrigine treatment
by: Seyede Maryam Naghibi, et al.
Published: (2023)

Mathematics And Medicine: Does It All Add Up?
by: Neil S Cherniack
Published: (2009)